Literature DB >> 11578968

The role of Epstein-Barr virus in systemic lupus erythematosus.

M T McClain1, J B Harley, J A James.   

Abstract

Systemic lupus erythematosus (SLE) is a devastating autoimmune disease with no known cure. Lupus patients suffer from a myriad of clinical symptoms which variably include arthritis, pleuritis, pericarditis, vasculitis, and nephritis. The underlying mechanisms behind these clinical findings and the etiologic events preceding and causing disease onset, however, remain largely unknown. For many years, investigators have suspected that Epstein-Barr virus might somehow be involved in the etiology and/or pathogenesis of systemic lupus. Numerous studies have examined this possibility from various angles and have arrived at different conclusions. This work reviews these historical papers in the context of new results and presents a hypothetical role for this virus as an etiological environmental trigger for SLE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578968     DOI: 10.2741/mcclain

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  8 in total

1.  Everyone comes from somewhere: systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunity.

Authors:  John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2010-06

2.  Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.

Authors:  M Chang; M-R Pan; D-Y Chen; J-L Lan
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 3.  SLE and infections.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 4.  Idiopathic Pericarditis-an Autoinflammatory Disease?

Authors:  Norbert Blank; Hanns-Martin Lorenz
Journal:  Curr Rheumatol Rep       Date:  2019-03-09       Impact factor: 4.686

5.  Infection and Activation of B Cells by Theiler's Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis.

Authors:  Young-Hee Jin; Charles X Kim; Jocelin Huang; Byung S Kim
Journal:  Cells       Date:  2020-07-27       Impact factor: 6.600

6.  Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma.

Authors:  Antonella Farina; Edoardo Rosato; Michael York; Benjamin E Gewurz; Maria Trojanowska; Giuseppina Alessandra Farina
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

Review 7.  Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease.

Authors:  Glinda S Cooper; Kathleen M Gilbert; Eric L Greidinger; Judith A James; Jean C Pfau; Leslie Reinlib; Bruce C Richardson; Noel R Rose
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

8.  Strong viral associations with SLE among Filipinos.

Authors:  Evan S Vista; Michael H Weisman; Mariko L Ishimori; Hua Chen; Rebecka L Bourn; Ben F Bruner; Laniyati Hamijoyo; Robelle D Tanangunan; Noga J Gal; Julie M Robertson; John B Harley; Joel M Guthridge; Sandra V Navarra; Judith A James
Journal:  Lupus Sci Med       Date:  2017-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.